NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 52 filers reported holding NOVELION THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
Prosight Management, LP | 194,663 | $716,000 | 0.52% |
ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |